[PP.29.26] AMBULATORY ARTERIAL STIFFNESS INDEX IN PATIENTS WITH METABOLIC SYNDROME AND NEWLY DIAGNOSED HYPERTENSION BEFORE AND AFTER ONE YEAR OF TREATMENT WITH LOSARTANE AND TELMISARTANE

2016 ◽  
Vol 34 ◽  
pp. e306
Author(s):  
I. Rihacek ◽  
M. Soucek ◽  
B. Kianicka ◽  
P. Frana ◽  
M. Plachy ◽  
...  
2011 ◽  
Vol 29 ◽  
pp. e220-e221
Author(s):  
A. Gonzalez ◽  
J. Ferrer ◽  
E. Silva ◽  
C. Esis ◽  
M. Bracho ◽  
...  

Renal Failure ◽  
2015 ◽  
Vol 37 (9) ◽  
pp. 1409-1413 ◽  
Author(s):  
Hakki Yilmaz ◽  
Muzaffer Cakmak ◽  
Osman Inan ◽  
Tahir Darcin ◽  
Aynur Aktas ◽  
...  

2021 ◽  
Vol 23 (Supplement_G) ◽  
Author(s):  
Angelica Cersosimo ◽  
Caterina Franco ◽  
Edoardo Sciatti ◽  
Gaia Favero ◽  
Enrico Vizzardi ◽  
...  

Abstract Aims Arterial hypertension, especially if not well-controlled, is one of the main risk factors predisposing to fatal cardiovascular diseases (CVDs). Moreover, the diagnosis of essential hypertension are increasing, therefore oxidative stress and chronic inflammation have also been identified as potential responsible for the development of endothelial damage. Among all the molecules, melatonin (MT) was chosen for its role as a powerful antioxidant and anti-inflammatory endogenous molecule. This trial aims to evaluate the early intervention at the base of the inflammatory and oxidative cascade (that results in the development of hypertension), to restore an oxidative balance leading to positive results even at the endothelial and vascular level using MT in addition to anti-hypertensive therapy. Methods The trial is randomized, prospective and monocentric control. We enrolled 23 patients with hypertension in absence of other cardiovascular or autoimmune diseases that could alter the oxidative background, from March 2018 to April 2019 (recruitment period). Patients were randomly assigned to two groups: ‘melatonin group’ (in which 16 patients add 1 mg/day of melatonin for a year, to their already settled therapy), and a ‘control’ group (consisting of 7 patients with no changes in their therapy). The average follow-up was 1 year from randomisation. Patients were evaluated before and after a period of 1 year through MT plasma concentration and serum antioxidant capacity (TAC) by specific quantitative ELISA method. Therefore endothelial dysfunction and arterial stiffness were evaluated too (using the non-invasive methods of EndoPAT and SphygmoCor). Results In ‘melatonin group’ arterial stiffness index statistically decreased (P 0.022), according to a significant increase in plasma melatonin values (P 0.003) and significant decrease in TAC levels (P 0.041) despite the ‘control’ group. The improvement of endothelial function was not significant (P 0.688). Blood pressure had not a significative improvement too (P 0.401). Conclusions Data obtained could confirm the hypothesis of activation of plasma antioxidant system against a situation of altered oxidative balance. In fact, it is possible to hypothesize a correlation between TAC and arterial stiffness that confirm the antioxidant role of MT. The combination between antihypertensive therapy and antioxidant supplementation is able to improve the vascular stiffness. Data obtained are still preliminary and present some limitations but we can think of proposing this trial as a future basis for other extensive and prolonged studies.


2015 ◽  
Vol 38 (9) ◽  
pp. 627-631 ◽  
Author(s):  
Anastasios Kollias ◽  
Vayia Rarra ◽  
Nikos Karpettas ◽  
Leonidas Roussias ◽  
Eoin O'Brien ◽  
...  

2016 ◽  
Vol 97 (1) ◽  
pp. 5-12
Author(s):  
L A Panchenkova ◽  
Kh A Khamidova ◽  
M O Shelkovnikova ◽  
T E Yurkova ◽  
N V Rassudova ◽  
...  

Aim. To evaluate 24-hour dynamics of the arterial stiffness main indicators in patients with arterial hypertension associated with metabolic syndrome, coronary heart disease and type 2 diabetes mellitus.Methods. The study included 54 patients with hypertension, who formed main groups: the first group - 17 patients with hypertension amid the metabolic syndrome, the second - 21 patients with metabolic syndrome and coronary heart disease, the third group - 16 patients with hypertension and type 2 diabetes mellitus. All patients underwent the vascular stiffness parameters study using a multifunctional complex for the 24-hour monitoring and office measurements of blood pressure and vessels condition. At the same time blood pressure, cardiac function and vascular stiffness indicators were examined: PWVao - pulse wave velocity in the aorta (m/s); PWTT - the pulse wave transit time (m/s); Aix - augmentation index (%); Asi - the arterial stiffness index. (mmHg).Results. When comparing the 24-hour arterial stiffness dynamics indicators, changes were found in all main patients groups compared to the healthy group. Thus, a statistically significant increase in the pulse wave velocity in the aorta (PWVao) in all groups of patients compared with the control group, a decrease in the index of the pulse wave transit time (PWTT) in all main groups of patients and a significant increase in arterial stiffness index (Asi) were found. When assessing the results of arterial stiffness monitoring at night time significantly larger values of the pulse wave velocity in the aorta were observed in patients with the metabolic syndrome and combination of metabolic syndrome and coronary heart disease. The obtained data are indicative of improvement in vascular stiffness indicators at night time in healthy individuals group, as well as maintaining a high degree of the vascular wall stiffness both in the night and in the daytime in a group of examined patients, especially in groups with the metabolic syndrome, and a combination of metabolic syndrome and coronary heart disease.Conclusion. 24-hour monitoring of vascular stiffness indicators in comorbid patients have revealed variability of the main indicators during the day; such arterial stiffness indicators as the pulse wave transit time, pulse wave velocity in the aorta, the arterial stiffness index, augmentation index can be used to assess early signs of the major arteries remodeling.


2018 ◽  
Vol 36 (Supplement 1) ◽  
pp. e179
Author(s):  
A. Merezhanova ◽  
E. Tarlovskaya ◽  
K. Mazalov ◽  
M. Mazalova ◽  
N. Kamardina ◽  
...  

2006 ◽  
Vol 24 (11) ◽  
pp. 2247-2253 ◽  
Author(s):  
Tine W Hansen ◽  
Jan A Staessen ◽  
Christian Torp-Pedersen ◽  
Susanne Rasmussen ◽  
Yan Li ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document